AXONICS INC (AXNX)

US05465P1012 - Common Stock

68.95  +0.05 (+0.07%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AXONICS INC

NASDAQ:AXNX (3/28/2024, 1:38:50 PM)

68.95

+0.05 (+0.07%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap3.52B
Shares
PE383.06
Fwd PE192.09
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AXNX Daily chart

Company Profile

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. The company is headquartered in Irvine, California and currently employs 610 full-time employees. The company went IPO on 2018-10-31. The company has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10 cubic centimeters (cc) in volume, utilizes constant current stimulation, a recharge-free patient remote control and offers broad magnetic resonance imaging (MRI) access. Its SNM systems include an easy-to-use wireless patient remote control that does not require recharging or replacement batteries. The company also offers a clinician programmer that guides the implanting physician through lead placement and stimulation programming.

Company Info

AXONICS INC

26 Technology Drive

Irvine CALIFORNIA 92618

P: 19493966322

CEO: Raymond W. Cohen

Employees: 610

Website: https://www.axonics.com/

AXNX News

News Image6 days ago - Axonics, Inc.Axonics Stockholders Approve Merger Agreement with Boston Scientific
News Image14 days ago - Axonics, Inc.Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
News Image20 days ago - Market News VideoNotable Friday Option Activity: PFE, AXNX, TEAM
News Image21 days ago - BloombergBoston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal

Boston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.

News Imagea month ago - Seeking AlphaMedtronic accuses Axonics of patent infringement, files ITC complaint (NASDAQ:AXNX)

Medtronic (MDT) has filed a complaint with the US International Trade Commission and a U.S. District Court accusing Axonics (AXNX) of patent infringement. Read more here.

News Imagea month ago - Axonics, Inc.Axonics Responds to ITC Action by Medtronic

AXNX Twits

Here you can normally see the latest stock twits on AXNX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example